Magnesium%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520sulphate

# Magnesium Sulphate ## Overview Magnesium sulphate is an essential mineral that plays a critical role in numerous physiological processes, including neuromuscular function, cardiac rhythm, and enzyme activity. It is available in oral and injectable forms. ## Primary Indications * **Hypomagnesemia:** Treatment of low magnesium levels. * **Eclampsia/Preeclampsia:** Prevention and treatment of seizures associated with severe preeclampsia and eclampsia. * **Torsades de Pointes:** Management of polymorphic ventricular tachycardia associated with a prolonged QT interval. * **Bronchodilation:** Adjunctive therapy in acute severe asthma exacerbations (less common, often limited evidence for routine use). * **Constipation (Oral):** Osmotic laxative. ## Adult Dosing **Hypomagnesemia:** * **Severe Deficiency (<1 mg/dL):** * **IV:** 4-6 grams (32-48 mEq) IV over 5-60 minutes, followed by an infusion of 1-2 grams (8-16 mEq) per hour until serum magnesium levels normalize or symptoms resolve. Maximum initial IV dose usually 6 grams. * **Moderate Deficiency (1-1.5 mg/dL):** * **IV:** 2-4 grams (16-32 mEq) IV infused over 5-60 minutes. * **IM:** 1 gram (8 mEq) IM every 4 hours for 4 doses. * **Oral:** Typically 1-3 grams (8-24 mEq) daily in divided doses. Doses vary based on formulation and desired effect. **Eclampsia/Peclampsia:** * **Loading Dose:** 4-6 grams (32-48 mEq) IV infused over 5-20 minutes. * **Maintenance Dose:** 2 grams (16 mEq) per hour IV infusion. Dosing may be adjusted based on clinical response and magnesium levels. Some protocols may include IM loading doses or boluses. Local protocol is critical. **Torsades de Pointes:** * **IV:** 2 grams (16 mEq) IV bolus over 5-10 minutes, followed by a continuous infusion of 1 gram (8 mEq) per hour. **Constipation (Oral):** * **IV:** Not indicated for constipation. * **Oral (Magnesium Citrate):** Typically 200-300 mL of a 7% solution. (Note: Magnesium citrate is a specific product; magnesium sulphate oral solutions also exist but are less commonly used for constipation due to taste). ## Pediatric Dosing Dosing is weight-based and requires careful calculation. Local protocols are essential. **Hypomagnesemia:** * **IV:** 25-50 mg/kg (0.2-0.4 mEq/kg) per dose IV infused over 10 minutes. May be repeated every 4-12 hours as needed. For severe deficiency, a loading dose of 100 mg/kg (0.8 mEq/kg) may be given over 4 hours, followed by a maintenance infusion of 30-50 mg/kg/hour (0.25-0.4 mEq/kg/hour). Maximum dose typically 2 grams. **Eclampsia/Preeclampsia:** * Generally similar to adult dosing, but specific protocols for pediatric patients are less common and may require expert consultation. ## Dose Adjustments * **Renal Impairment:** Magnesium is renally excreted. Dose reduction and careful monitoring of serum magnesium levels are necessary in patients with impaired renal function. In severe renal impairment, magnesium sulphate should be used with extreme caution or avoided. ## Contraindications * Hypermagnesemia. * Heart block. * Myocardial infarction with conduction defects. * Hypermagnesemia may also be a contraindication in severe renal failure. ## Adverse Effects * **Common:** Flushing, sweating, hypotension, nausea, vomiting, drowsiness, decreased reflexes, hypothermia. * **Serious:** Respiratory depression, cardiac arrest, arrhythmias, hypermagnesemia (muscle weakness, absent deep tendon reflexes, confusion, somnolence, bradycardia, hypotension, respiratory arrest, cardiac arrest). ## Key Drug Interactions * **Neuromuscular Blockers:** Magnesium can potentiate the neuromuscular blockade caused by non-depolarizing neuromuscular blocking agents. * **Calcium:** IV calcium administration may antagonize the effects of magnesium. * **Tetracyclines and Bisphosphonates:** Oral magnesium can decrease the absorption of these drugs. Administer oral magnesium at least 2 hours before or 4-6 hours after these agents. * **Digitalis:** Hypermagnesemia can cause cardiac arrhythmias in patients taking digitalis. ## Monitoring * **Serum Magnesium Levels:** Essential, especially with IV administration and in renal impairment. Target levels vary by indication. * **Renal Function:** Monitor BUN and creatinine. * **Vital Signs:** Blood pressure, heart rate, respiratory rate. * **Neurological Status:** Level of consciousness, deep tendon reflexes. * **Urine Output:** Adequate renal function is crucial for magnesium excretion. * **ECG:** Particularly important in cardiac indications. ## Clinical Pearls * Magnesium sulphate is a potent medication; accurate dosing and careful monitoring are crucial. * Always verify the concentration of the magnesium sulphate solution before administration. * For IV administration, a slow infusion rate is essential to prevent hypotension and other adverse effects. * In eclampsia, monitor for signs of magnesium toxicity, including decreased respiratory rate, absent reflexes, and hypotension. Have calcium gluconate readily available as an antidote. * Oral magnesium sulphate can cause diarrhea; magnesium citrate is often preferred for constipation due to palatability and efficacy. * Ensure adequate hydration when using oral magnesium as a laxative. *** *Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols for definitive guidance. Dosing and management may vary based on patient-specific factors and local guidelines.*